Literature DB >> 33717543

Comparison of short-term clinical outcomes between robot-assisted minimally invasive esophagectomy and video-assisted minimally invasive esophagectomy: a systematic review and meta-analysis.

Chao Zheng1, Xiao-Kun Li1, Chi Zhang2, Hai Zhou3, Sai-Guang Ji3, Ji-Hong Zhong2, Yang Xu4, Zhuang-Zhuang Cong2, Gao-Ming Wang5, Wen-Jie Wu6, Yi Shen1,2,3.   

Abstract

BACKGROUND: Though robot-assisted minimally invasive esophagectomy (RAMIE) is demonstrated to offer a better visualization and provide a fine dissection of the mediastinal structures to facilitate the complex thoracoscopic operation, the superiorities of RAMIE over MIE have not been well verified. The aim of this study was to explore the actual superiorities through comparing short-term results of RAMIE with that of MIE.
METHODS: PubMed, EMBASE and web of science databases were systematically searched up to September 1, 2020 for case-controlled studies that compared RAMIE with TLMIE.
RESULTS: Fourteen studies were identified, with a total of 2,887 patients diagnosed with esophageal cancer, including 1,435 patients subjected to RAMIE group and 1,452 patients subjected to MIE group. The operative time in RAMIE was still significantly longer than that in MIE group (OR =0.785; 95% CI, 0.618-0.952; P<0.001). The incidence of pneumonia was significantly lower in RAMIE group compared with MIE group (OR =0.677; 95% CI, 0.468-0.979; P=0.038).
CONCLUSIONS: RAMIE has the superiorities over MIE in short-term outcomes in terms of pneumonia and vocal cord palsy. Therefore, RAMIE could be considered as a standard treatment for patients with esophageal cancer. 2021 Journal of Thoracic Disease. All rights reserved.

Entities:  

Keywords:  Robot-assisted minimally invasive esophagectomy (RAMIE); meta-analysis; short-term clinical outcomes; video-assisted minimally invasive esophagectomy

Year:  2021        PMID: 33717543      PMCID: PMC7947517          DOI: 10.21037/jtd-20-2896

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


Introduction

Esophageal cancer poses a serious global health burden with high morbidity and mortality rates (1,2). The long-term prognosis of esophageal cancer remains poor with a 5-year overall survival rate of about 15–34% (3,4). Radical esophagectomy with lymphadenectomy is still the primary treatment for patients with esophageal cancer (5). Conventional open thoracotomy for esophagectomy was found to have considerable morbidity and mortality rates (6). Minimally invasive esophagectomy (MIE), with less invasiveness compared to open thoracotomy, has become increasingly prevalent in the treatment of resectable esophageal cancer since the early 2000s (7). Recently, robot-assisted minimally invasive esophagectomy (RAMIE) has also been introduced, which showed significant superiorities of increased magnification, three-dimensional visual clarity, and dexterity (8-10). It filters out the tremor of the surgeon, restores the natural hand-eye coordination axis as a result of the ergonomically designed surgeon’s console, and offers more degrees of freedom through its articulating surgical instruments (9,11). Although RAMIE is demonstrated to offer better visualization and enable meticulous dissection of the mediastinum structures facilitating the complex thoracoscopic procedures, the actual superiorities of RAMIE over MIE have not been well verified (10). Several retrospective studies have found that RAMIE was equivalent or even superior to MIE in radical lymphadenectomy. There was only one meta-analysis that compares RAMIE to MIE in 2019 (12). This meta-analysis includes 8 case control studies and no randomized controlled trials. It concluded that RAMIE and MIE display similar effects and safety in the treatment of esophageal cancer. RAMIE could reduce the risk of recurrent laryngeal nerve damage due to improved vision and flexibility during the paratracheal lymph node dissection. However, more high-quality studies have been published until now. The aim of this study was to investigate the actual advantages of RAMIE over MIE by comparing short-term outcomes of RAMIE with that of MIE. We present the following article in accordance with the PRISMA reporting checklist (available at http://dx.doi.org/10.21037/jtd-20-2896).

Methods

PubMed, EMBASE, and web of science were searched from 1980 to September 1, 2020. Medical subject heading (MeSH) and Thesaurus were used in PubMed and OVID, respectively. According the PICOs, the keywords were determined and identical in the two databases (Medline and EMBASE): “Esophag*”, “Esophag* Neoplasm*”, “Esophag* Cancer*”, “Esophag* resection”, “Robot*”. The PICO format was adopted to establish specific selection criteria in which P was referred to patients undergoing MIE, I was referred to RAMIE, C was referred to thoraco-laparoscopic MIE (TLMIE), O was referred to the short-term clinical outcomes. The design style was limited to case-control studies. Only articles published in English met the inclusion criteria. In this meta-analysis, short-term clinical outcomes were classified into infectious complications, including pneumonia, anastomotic leakage, empyema and surgical site infection, and surgical relevant complications, composed of chylothorax and vocal cord palsy, as well as mortality and the length of hospital and ICU stay. The following studies were excluded: narrative or expert reviews, experimental data such as animal studies or trials, unable to acquire primary data and essential information from authors, articles published not in English. The following patients were excluded: patients lost for follow-up, patients discontinued intervention, patients combined with other cancers, patients did not undergo MIE, patients with major organic dysfunction, patients with severe preoperative infection.

Quality assessment

Selected studies were all case-control studies thus NOS was used for grading. The risk of bias assessment was carried out by two reviewers independently (Chao Zheng, Chi Zhang). A third reviewer (Xiao-Kun Li) arbitrated unresolved disagreements.

Statistical analysis

Stata 15.1 was applied in data analyses. Forest plots were conducted to show the pooled estimate for the studies. The continuous outcome variables were presented through weighted mean difference (WMD) with 95% confidence interval (CI), if the same unit and magnitude were applied in all the included researches; otherwise, standard mean difference (SMD) would be applied. Dichotomous outcomes were evaluated using odds ratio (OR) with 95% CI. In studies that only reported medians and ranges, the mean and standard deviation (SD) were assessed using the means of the method provided by Hozo et al. (13). Heterogeneity was evaluated by χ2 based test and p value. If small heterogeneity was observed (I2<50% or P>0.05), the fixed-effect model was used; if not, the random-effect model would be used. Sensitivity analysis would be used to investigate the source of heterogeneity. Publication bias was assessed using funnel plot, and Egger’s test or Begg’s test would be conducted if needed. A P value of less than 0.05 was considered as statistically significant.

Results

Basic characteristics

Literature research and selection in this meta-analysis were shown in . A total of 1,183 studies were systematically searched from the three electronic databases, after removing 288 duplicates. After reviewing titles and abstracts, 828 studies were removed due to not fulfilling the inclusion criteria. The full-text of remaining 67 studies were further screened. Finally, 14 studies (9,10,14-25) were included finally, with a total of 2,887 patients, including 1,435 patients subjected to RAMIE group and 1,452 patients subjected to TLMIE group. All the included studies reported that the thoracic procedure of esophagectomy was via thoracic approach rather than cervical approach. The reconstruction of the esophagus and gastric conduit was done through cervical anastomosis in most researches. The basic characteristics of included researches are presented in . Seven out of 14 studies were carried out in China. All studies were of high-quality score based on NOS. The characteristics and methodological quality assessment scores of the included studies are summarized in .
Figure 1

Flow chart of selection for included studies.

Table 1

Characteristics of the selected studies included in the meta-analysis

StudyCountryGroupNAge, yearsBMI, kg/m2Site (upper/mid/lower)Pathology (ESCC/EAC)Neoadjuvant therapyTumor size (cm)Surgical procedures
Suda 2012JapanRAMIE1665 [53–86]21.3 (17.5–26.3)2/7/916/063.75 [0.9–8.0]NA
MIE2064.5 [50–79]20.4 (14.9–24.8)2/12/620/0173.65 [0.0–7.0]NA
Weksler 2012AmericanRAMIE1158.7±8.527.1NA0/104NAIvor-Lewis
MIE2664.3±11.327.9NA3/2310NAIvor-Lewis
Yerokun 2016CanadaRAMIE17056/64/70NA0/156/14NA12020.0/35.0/50.0NA
MIE17056/63/69NA0/160/10NA12022.5/35.0/50.0NA
Park 2016South KoreaRAMIE6264.3±8.023.5±2.88/15/3962/08NAMckown
MIE4364.3±8.023.3±3.17/9/2743/04NAMckown
Weksler 2017AmericanRAMIE56962.9±9.6NANA/513/NA114/45540533.7 [17–57]NA
MIE56962.8±9.3NANA/527/NA114/45540135.0 [15–55]NA
Chao 2018ChinaRAMIE3456.76±8.39NA10/15/934/017NAMckown
MIE3453.47±8.69NA10/19/934/017NAMckown
Deng 2018ChinaRAMIE4260.7±6.9NANA42/0NANAMckown
MIE4261.8±9.5NANA42/0NANAMckown
Deng 2018ChinaRAMIE5261.0±7.2NA10/33/952/0NANAMckown
MIE5260.9±9.2NA7/30/1452/0NANAMckown
He 2018ChinaRAMIE2761.0±8.021.5±2.71/18/823/4NANAMckown
MIE2761.6±9.821.9±2.83/15/925/2NANAMckown
Chen 2019ChinaRAMIE5461.8±9.422.7±2.9NA54/0NANAMckown
MIE5461.8±8.323.0±2.7NA54/0NANAMckown
Motoyama 2019JapanRAMIE2163 [44–76]NA6 /7/821/012NANA
MIE3866 [49–75]NA9/16/1338/019NANA
Tagkolos 2019GermanyRAMIE506226.13NANANANAIvor-Lewis
MIE506424.89NANANANAIvor-Lewis
Yang 2019ChinaRAMIE27163.4±7.1NA38/169/64271/029NAMckown
MIE27163.5±7.4NA31/171/69271/028NAMckown
Zhang 2019ChinaRAMIE6662.3±7.822.9±3.10/29/3764/2NA3.1±1.4Ivor-Lewis
MIE6662.0±7.823.1±4.50/26/4065/1NA3.0±1.4Ivor-Lewis
Table 2

The Newcastle-Ottawa scale

StudySelectionComparabilityExposureTotal quality scores
12341123
Suda 20127
Weksler 20127
Yerokun 20167
Park 2016★★8
Weksler 2017★★8
Chao 20187
Deng 2018★★8
Deng 2018★★8
He 2018★★8
Chen 2019★★8
Motoyama 20197
Tagkolos 20197
Yang 2019★★8
Zhang 2019★★8
Flow chart of selection for included studies.

Meta-analysis

Operative time was reported in 11 studies including 1,270 participates. The data was deemed to be heterogeneity (χ2=165.04, P<0.0001, I2=93.9%). Random-effect model was adopted. The operative time in RAMIE was significantly longer than that in MIE group (WMD =30.929; 95% CI, 4.357–57.500; P=0.023). To find out the source of large heterogeneity, we did a sensitivity analysis and exclude the results conducted by Yang et al. (23) and Chen et al. (22) to make the I2 to 74.4%. The pooled results were recalculated through a random effect model, and the operative time in RAMIE was still significantly longer than that in MIE group (WMD =45.497; 95% CI, 25.900–65.093; P<0.001) (). The postoperative complications were reported in six studies enrolling 1,021 patients. Heterogeneity was identified (χ2=2.38, P=0.79, I2=0.0%), and fixed effect model was used. No significant difference was found between two groups (OR =1.24; 95% CI, 0.951–1.617; P=0.11). Eleven studies reported data regarding the incidence of anastomotic leak which enrolled 1352 patients. Heterogeneity was not observed (χ2=10.10, P=0.432, I2=1.0%), and the forest plot was done using fixed-effect model and no significant difference was observed between RAMIE group and MIE group (OR =1.127; 95% CI, 0.781–1.625; P=0.52). Egger test was used to assess publication bias and no publication bias was found in the meta-analysis of the incidence of anastomotic leak (P=0.058) (). We furtherly conducted a sub-analysis due to different approaches of anastomosis, and the result indicated that no significant difference was observed between two groups no matter cervical anastomosis or thoracic anastomosis were performed (Figure S1). Chylothorax was reported in six researches consisting of 518 patients. Heterogeneity was identified (χ2=0.61, P=0.99, I2=0.0%), and fixed-effect model was used. No significant difference was found in the incidence of chylothorax between two groups (OR =0.41; 95% CI, 0.125–1.32; P=0.13). Nine studies including 1,191 patients reported the incidence of pneumonia. Statistical heterogeneity was not significant (χ2=3.55, P=0.90, I2=0.0%). The incidence of pneumonia in RAMIE group was significantly lower than that in MIE group (OR =0.677; 95% CI, 0.468–0.979; P=0.038). The incidence of surgical site infection was reported in 4 studies including 791 patients. Heterogeneity was identified (χ2=2.14, P=0.54, I2=0.0%). Fixed effect model was used and there was no significant difference between two groups (OR =1.42; 95% CI, 0.412–4.882; P=0.58) (). Ten studies reported vocal cord paralysis, including 1,270 patients. The significant heterogeneity (χ2=27.97, P=0.001, I2=67.28%) was observed, then random-effect model was used. There was no significant difference between RAMIE group and MIE group (OR =0.833; 95% CI, 0.439–1.581; P=0.576). To find out the source of large heterogeneity, we did a sensitivity analysis and excluded the results conducted by Yang et al. to make the I2 to 19.6%. The pooled results were recalculated through a fixed-effect model, the incidence of vocal cord palsy was significantly different between two groups (OR =0.624; 95% CI, 0.411–0.947; P=0.027) (). 30 days mortality was reported in 7 studies including 1,947 patients. Heterogeneity was identified (χ2=2.83, P=0.587, I2=0.0%). Fixed effect model was used and no significant difference was found between RAMIE group and MIE group (OR =1.678; 95% CI, 0.986–2.857; P=0.056). 90 days mortality was also reported in 7 studies including 2,165 participates. Heterogeneity was identified (χ2=10.06, P=0.790, I2=0.0%) and fixed effect model was used. No significant difference was seen between two groups (OR =1.106; 95% CI, 0.754–1.621; P=0.777) ().
Figure 2

Comparison of operative time between RAMIE and MIE (A) and after excluding two studies (B). RAMIE, robot-assisted minimally invasive esophagectomy; MIE, minimally invasive esophagectomy.

Figure 3

Comparison of the incidence of postoperative complications (A) and anastomotic leak (B) with responding Eger’s test (C) between RAMIE and MIE. RAMIE, robot-assisted minimally invasive esophagectomy; MIE, minimally invasive esophagectomy.

Figure 4

Comparison of the incidence of chylothorax (A), pneumonia (B), and surgical site infection (C) between RAMIE and MIE. RAMIE, robot-assisted minimally invasive esophagectomy; MIE, minimally invasive esophagectomy.

Figure 5

Comparison of the incidence of vocal cord palsy between RAMIE and MIE. RAMIE, robot-assisted minimally invasive esophagectomy; MIE, minimally invasive esophagectomy.

Figure 6

Comparison of the 30-day (A) and 90-day mortality (B) between RAMIE and MIE. RAMIE, robot-assisted minimally invasive esophagectomy; MIE, minimally invasive esophagectomy.

Comparison of operative time between RAMIE and MIE (A) and after excluding two studies (B). RAMIE, robot-assisted minimally invasive esophagectomy; MIE, minimally invasive esophagectomy. Comparison of the incidence of postoperative complications (A) and anastomotic leak (B) with responding Eger’s test (C) between RAMIE and MIE. RAMIE, robot-assisted minimally invasive esophagectomy; MIE, minimally invasive esophagectomy. Comparison of the incidence of chylothorax (A), pneumonia (B), and surgical site infection (C) between RAMIE and MIE. RAMIE, robot-assisted minimally invasive esophagectomy; MIE, minimally invasive esophagectomy. Comparison of the incidence of vocal cord palsy between RAMIE and MIE. RAMIE, robot-assisted minimally invasive esophagectomy; MIE, minimally invasive esophagectomy. Comparison of the 30-day (A) and 90-day mortality (B) between RAMIE and MIE. RAMIE, robot-assisted minimally invasive esophagectomy; MIE, minimally invasive esophagectomy.

Discussion

According to the only randomized controlled trial so far, MIE was found to be superior to open esophagectomy in terms of intraoperative blood loss, acute immunological response, postoperative pulmonary infections, length of hospital stay, postoperative pain scores, and quality of life (7). Although MIE seems to improve short-term clinical outcomes, it is a highly complex procedure to master due to the combination of two-dimensional vision, mirrored intracorporeal movements of the instruments, moving target anatomy, and nearby vital structures that need to be avoided (7,8,25,26). Therefore, RAMIE was introduced to aid in overcoming the technical limitations of conventional MIE, showing significant superiority of increased magnification, three-dimensional visual clarity, and dexterity (24,27). A ROBOT trial was conducted, which compared RAMIE to open esophagectomy regarding postoperative morbidity, mortality, and survival (28). A total of 112 patients were randomized in a high-volume tertiary referral center that was experienced in both techniques (28). The overall complication rate was significantly lower in the RAMIE group, which was likely attributable to significantly lower rates of cardiac complications (47% vs. 22%) and pulmonary complications (32% vs. 58%) (29). Furthermore, RAMIE was associated with less intraoperative blood loss, lower postoperative pain scores, faster functional recovery, and better quality of life when compared to open esophagectomy. Whether RAMIE has any superiorities over MIE on short-term clinical outcomes remains controversial. There was only one meta-analysis reported by Jin et al. (12), including 8 studies, comparing the short-term clinical outcomes between RAMIE and the conventional MIE. There were no significant differences between RAMIE and MIE in terms of postoperative complications, length of hospital stays or mortality. We conducted this meta-analysis, enrolling 14 high-quality retrospective studies, to further evaluate the short-term clinical outcomes in RAMIE by comparing with that in MIE. According to the results, the incidences of pneumonia and vocal cord palsy were significantly lower in RAMIE group than that in MIE group. The potential reasons why RAMIE has the superiorities over MIE could be explained as followed: (I) RAMIE provided a three-dimensional visualization with ten-times-enlarged image and superior imaging quality facilitating identifying various structures during operations. (II) RAMIE provided with freely articulated movement of the robotic arms and seven-degree freedom of its dexterity endowrists which make surgeons operate in a stable and comfortable environment, enabling more precise dissection and avoiding nerve injury especially in vocal cord palsy as well as other structures injury during lymphadenectomy. The incidence of anastomotic leak in RAMIE group was tended to be higher than that in MIE group. This may be because of the induced ischemia of the stump caused by too much exposure of the cranial end of the divided esophagus which could be due to the robotic system providing a better surgical view and more accurate dissection than the standard thoracoscopic approach. There was no significant difference between two groups in 30-day mortality and 90-day mortality which at least demonstrated that RAMIE was equivalent to MIE in terms of safety. However, the operative time in RAMIE was significantly longer than that in MIE. The potential reasons may be: (I) the robotic carts need to be repositioned between the thoracic phase and the abdominal phase which result in RAMIE needing to install twice in each operation; (II) surgeons were more familiar with MIE since they have performed MIE for many years while only conducted RAMIE for a few years. With the development of robotic technique and surgeons’ proficiency, the operative time would be shortened according to the learning curve. The operative time in RAMIE group in the study of Yang et al. reported in 2019 was significantly longer than that in MIE group (P<0.001) (23). Meanwhile, in the study of Chen et al. reported in 2019, the mean operative time in RAMIE was also longer than that in MIE, however, there was no significant difference (22). Four studies reported long-term outcomes. The difference of 5-year overall survival (69% vs. 59% for RAMIE and MIE, respectively, P=0.737) demonstrated in the study of Park et al. (15) was not statistically significant. Similarly, Weksler et al. (17) reported that the median survival time between two groups (48 vs. 49 months for RAMIE and MIE, respectively, P>0.05) was not significantly different. Besides, both Yerokun et al. (16) and Yang et al. (23) demonstrated that no significant difference among RAMIE group and MIE group was observed in terms of 3-year overall survival. In addition, Yang et al. (23) also reported 3-year disease-free survival (DFS) and the results indicated that there was no statistical difference in DFS between RAMIE and MIE groups. Despite several studies used PSM analysis, they still cannot rule out the presence of potential selection biases due to the retrospective nature of these studies, meanwhile, longer follow-up is needed to compare the long-term outcomes between two groups. Therefore, RCTs with long-term follow-up were urgently warranted to compare these two approaches. Yang et al. launched a prospectively RCT (RAMIE trial, ClinicalTrial.gov: NCT03094351) to compare RAMIE and MIE in March 2017 (11). Chao et al. also conducted a prospectively RCT registered on 22 October 2018 (ClinicalTrial.gov: NCT03094351) to compare the two techniques (30).

Conclusions

RAMIE has better short-term outcomes than MIE in terms of pneumonia and vocal cord palsy. However, there were no significant differences in overall and disease-free survival as well as short-term mortality between the two groups. Therefore, RAMIE could be considered as a standard treatment for patients with esophageal cancer. The article’s supplementary files as
  30 in total

1.  Robot-assisted minimally invasive esophagectomy (RAMIE) compared to conventional minimally invasive esophagectomy (MIE) for esophageal cancer: a propensity-matched analysis.

Authors:  E Tagkalos; L Goense; M Hoppe-Lotichius; J P Ruurda; B Babic; E Hadzijusufovic; W Kneist; P C van der Sluis; H Lang; R van Hillegersberg; P P Grimminger
Journal:  Dis Esophagus       Date:  2020-04-15       Impact factor: 3.429

2.  Comparison of short-term outcomes between robot-assisted minimally invasive esophagectomy and video-assisted minimally invasive esophagectomy in treating middle thoracic esophageal cancer.

Authors:  H-Y Deng; W-X Huang; G Li; S-X Li; J Luo; G Alai; Y Wang; L-X Liu; Y-D Lin
Journal:  Dis Esophagus       Date:  2018-08-01       Impact factor: 3.429

3.  Robot-assisted thoracoscopic lymphadenectomy along the left recurrent laryngeal nerve for esophageal squamous cell carcinoma in the prone position: technical report and short-term outcomes.

Authors:  Koichi Suda; Yoshinori Ishida; Yuichiro Kawamura; Kazuki Inaba; Seiichiro Kanaya; Satoshi Teramukai; Seiji Satoh; Ichiro Uyama
Journal:  World J Surg       Date:  2012-07       Impact factor: 3.352

4.  Robot-assisted minimally invasive esophagectomy is equivalent to thoracoscopic minimally invasive esophagectomy.

Authors:  B Weksler; P Sharma; N Moudgill; K A Chojnacki; E L Rosato
Journal:  Dis Esophagus       Date:  2011-09-07       Impact factor: 3.429

5.  Outcome of patients with esophageal cancer: a nationwide analysis.

Authors:  Miao-Fen Chen; Yao-Hsu Yang; Chia-Hsuan Lai; Pau-Chung Chen; Wen-Cheng Chen
Journal:  Ann Surg Oncol       Date:  2013-03-23       Impact factor: 5.344

6.  Cancer statistics in China, 2015.

Authors:  Wanqing Chen; Rongshou Zheng; Peter D Baade; Siwei Zhang; Hongmei Zeng; Freddie Bray; Ahmedin Jemal; Xue Qin Yu; Jie He
Journal:  CA Cancer J Clin       Date:  2016-01-25       Impact factor: 508.702

7.  Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer: A Randomized Controlled Trial.

Authors:  Pieter C van der Sluis; Sylvia van der Horst; Anne M May; Carlo Schippers; Lodewijk A A Brosens; Hans C A Joore; Christiaan C Kroese; Nadia Haj Mohammad; Stella Mook; Frank P Vleggaar; Inne H M Borel Rinkes; Jelle P Ruurda; Richard van Hillegersberg
Journal:  Ann Surg       Date:  2019-04       Impact factor: 12.969

8.  Clinical utility of robot-assisted transthoracic esophagectomy in advanced esophageal cancer after neoadjuvant chemoradiation therapy.

Authors:  Jae Kwang Yun; In-Seob Lee; Chung-Sik Gong; Bum Soo Kim; Hyeong Ryul Kim; Dong Kwan Kim; Seung-Il Park; Yong-Hee Kim
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

9.  Estimating the mean and variance from the median, range, and the size of a sample.

Authors:  Stela Pudar Hozo; Benjamin Djulbegovic; Iztok Hozo
Journal:  BMC Med Res Methodol       Date:  2005-04-20       Impact factor: 4.615

10.  Robot-assisted esophagectomy (RAE) versus conventional minimally invasive esophagectomy (MIE) for resectable esophageal squamous cell carcinoma: protocol for a multicenter prospective randomized controlled trial (RAMIE trial, robot-assisted minimally invasive Esophagectomy).

Authors:  Yang Yang; Xiaobin Zhang; Bin Li; Zhigang Li; Yifeng Sun; Teng Mao; Rong Hua; Yu Yang; Xufeng Guo; Yi He; Hecheng Li; Hezhong Chen; Lijie Tan
Journal:  BMC Cancer       Date:  2019-06-21       Impact factor: 4.430

View more
  5 in total

Review 1.  Advanced Robotic Surgery: Liver, Pancreas, and Esophagus - The State of the Art?

Authors:  Pasquale Scognamiglio; Björn-Ole Stüben; Asmus Heumann; Jun Li; Jakob R Izbicki; Daniel Perez; Matthias Reeh
Journal:  Visc Med       Date:  2021-11-12

2.  A retrospective study of preoperative malnutrition based on the Controlling Nutritional Status score as an associated marker for short-term outcomes after open and minimally invasive esophagectomy for esophageal cancer.

Authors:  Tomo Horinouchi; Naoya Yoshida; Kazuto Harada; Kojiro Eto; Hiroshi Sawayama; Masaaki Iwatsuki; Shiro Iwagami; Yoshifumi Baba; Yuji Miyamoto; Hideo Baba
Journal:  Langenbecks Arch Surg       Date:  2022-08-17       Impact factor: 2.895

Review 3.  Current status of robot-assisted minimally invasive esophagectomy: what is the real benefit?

Authors:  Jun Kanamori; Masayuki Watanabe; Suguru Maruyama; Yasukazu Kanie; Daisuke Fujiwara; Kei Sakamoto; Akihiko Okamura; Yu Imamura
Journal:  Surg Today       Date:  2021-12-01       Impact factor: 2.540

Review 4.  Selection of minimally invasive surgical approaches for treating esophageal cancer.

Authors:  Yu-Kwang Lee; Ke-Cheng Chen; Pei-Ming Huang; Shuenn-Wen Kuo; Mong-Wei Lin; Jang-Ming Lee
Journal:  Thorac Cancer       Date:  2022-06-15       Impact factor: 3.223

5.  Robot-assisted minimally invasive esophagectomy versus video-assisted minimally invasive esophagectomy: a systematic review and meta-analysis.

Authors:  Hao Chen; Yiyang Liu; Hao Peng; Rongchun Wang; Kang Wang; Demin Li
Journal:  Transl Cancer Res       Date:  2021-11       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.